IHS Chemical Week

Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients

Nycomed JV Opens API Facility in India

2:47 AM MDT | September 29, 2010 | Deepti Ramesh

Nycomed (Zurich, Switzerland) says its Zydus Nycomed (Navi Mumbai, India) joint venture with Zydus Cadila (Ahmedabad, India) has commissioned its expanded active pharmaceutical ingredients (API) manufacturing facility at Navi Mumbai, and the company is expected to start commercial production of APIs by December. The plant will initially manufacture pantoprazole, urapidil and lornoxicam, and by 2011 it will produce eight additional APIs. Zydus Nycomed is a 50-50 jv, which was formed in 1998. Nycomed had announced in 2008 that it plans to transfer production of...

This information is only available to Chemical Week subscribers.

Username:
Password:

Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

  • Searchable online archive access of the last 2 years of Chemical Week.
  • Print or digital magazine subscription
  • Price and market change alerts
  • Economic data and statistics
  • Buyers' Guides
  • Webcasts | whitepapers

 

 

 













 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2014 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa